Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole as an Adjunct of Non-Surgical Treatment of Peri-implantitis
NCT03564301Phase 4Completed
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in peri-implantitis comparing Metronidazole 250mg with Placebo (2 arms). Primary endpoint: Change in probing depth at 6 months. Started Mar 2018; status: completed.
02
Drugs
metronidazole
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT03564301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03564301.